147 results on '"Sun, Zhifu"'
Search Results
2. Data from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
3. Supplementary Table 2 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
4. Data from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
5. Supplementary Table 3 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
6. Supplementary Table 1 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
7. Supplementary Table 1 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
8. Supplementary Table 3 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
9. Data from Fine Mapping of Chromosome 6q23-25 Region in Familial Lung Cancer Families Reveals RGS17 as a Likely Candidate Gene
10. Data from Fine Mapping of Chromosome 6q23-25 Region in Familial Lung Cancer Families Reveals RGS17 as a Likely Candidate Gene
11. Supplementary Tables 1-4 from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
12. Supplemental Figures 1-6 from New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice
13. Supplemental Table 2 from New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice
14. Supplementary Figure 1 from Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
15. Supplementary Data from Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma
16. Supplementary Data from Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma
17. Translation on this Article from Fine Mapping of Chromosome 6q23-25 Region in Familial Lung Cancer Families Reveals RGS17 as a Likely Candidate Gene
18. Supplementary Figure 3C from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
19. Supplementary Figure 2B from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
20. Supplementary Figure 1C from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
21. Supplementary Table 4D from Global Methylation Profiling for Risk Prediction of Prostate Cancer
22. Data from Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy
23. Supplementary Figure 3B from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
24. Supplemental Table 1 from New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice
25. Data from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
26. Supplemental legend from Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors
27. Translation on this Article from Fine Mapping of Chromosome 6q23-25 Region in Familial Lung Cancer Families Reveals RGS17 as a Likely Candidate Gene
28. Supplementary Table 1 from Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
29. Supplementary Table 1D from Global Methylation Profiling for Risk Prediction of Prostate Cancer
30. Supplementary Table 1B from Global Methylation Profiling for Risk Prediction of Prostate Cancer
31. Supplementary Table 1D from Global Methylation Profiling for Risk Prediction of Prostate Cancer
32. Supplementary Table 2 from Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
33. Supplementary Table 1C from Global Methylation Profiling for Risk Prediction of Prostate Cancer
34. Supplementary Table 6 from Global Methylation Profiling for Risk Prediction of Prostate Cancer
35. Supplementary Figure 3B from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
36. Supplementary Figure 4A from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
37. Supplementary Figure 1A from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
38. Supplementary Figure 4C from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
39. Supplementary Table 4C from Global Methylation Profiling for Risk Prediction of Prostate Cancer
40. Supplementary Figure 4C from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
41. Supplemental Table 1 from New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice
42. Supplementary Figure 2B from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
43. Supplementary Table 1 from Glutathione Pathway Genetic Polymorphisms and Lung Cancer Survival After Platinum-Based Chemotherapy
44. Supplementary Table 4A from Global Methylation Profiling for Risk Prediction of Prostate Cancer
45. Supplementary Table 5 from Global Methylation Profiling for Risk Prediction of Prostate Cancer
46. Supplementary Figure 3C from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
47. Supplementary Figure 3D from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy
48. Supplementary Figure 2 from Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
49. Supplementary Table 2 from Global Methylation Profiling for Risk Prediction of Prostate Cancer
50. Supplementary Table 1 from Glutathione Pathway Genetic Polymorphisms and Lung Cancer Survival After Platinum-Based Chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.